[1]
Den Hollander, D. et al. 2019. Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST). Acta Oncologica. 58, 11 (Nov. 2019), 1648–1654. DOI:https://doi.org/10.1080/0284186X.2019.1637017.